Categories: MedicaidMedicareNews

SpectraMedix Expands Value-Based Payment (VBP) Contract Modeler to Support the Industry’s Most Comprehensive Range of Value-Based Contract Types

Innovative solution simplifies value-based contracting and scenario modeling, fostering sustainable, mutually beneficial arrangements.

EAST WINDSOR, N.J., Jan. 7, 2025 /PRNewswire/ — SpectraMedix, a leader in advanced analytics and technology solutions for value-based payment (VBP) models, announces that its VBP Contract Modeler now supports the broadest portfolio of value-based contracts in the industry. Already utilized by health plans and health systems in over 20 states, this expansion reinforces SpectraMedix’s commitment to driving the adoption of sustainable and impactful value-based contracts.

The enhanced SpectraMedix VBP Contract Modeler enables users to automate the modeling and development of diverse value-based contract models spanning pay-for-quality (P4Q), shared savings, shared risk, and capitation across all lines of business. By streamlining contract design and simulation, SpectraMedix empowers health plans and health systems to test scenarios and explore different risk-sharing and payout structures to construct value-based contracts that align with their unique objectives and drive meaningful results.

“Over the past five years, the SpectraMedix VBP Contract Modeler has become the gold standard for actuaries and contracting teams, enabling health plans and health systems to critically evaluate, develop, and negotiate the next generation of value-based contracts,” said Raj Lakhanpal, MD, CEO of SpectraMedix. “Our solution empowers clients to simulate performance across various contract types and scenarios, helping them build sustainable arrangements that offer the right balance across quality, cost, utilization and risk—ultimately benefiting their providers and the populations they serve.”   

An Integrated Solution for Value-Based Arrangements

The VBP Contract Modeler is seamlessly embedded in the SpectraMedix VBP Platform, providing an all-in-one solution encompassing AI-powered analytics, contract modelling and settlement, and provider enablement tools. This comprehensive solution supports strategic decision-making across commercial, Medicare and Medicaid markets, helping health plans and health systems unlock the full potential of their value-based arrangements. For more information on the SpectraMedix VBP Contract Modeler or the SpectraMedix VBP Platform, visit https://www.spectramedix.com/spectramedix-value-based-platform.

About SpectraMedix

SpectraMedix delivers the complete picture of value-based performance to drive operational excellence and accelerate performance improvement for health plans and health systems across the spectrum of value-based contracts. Our comprehensive, end-to-end platform empowers organizations with transparency into financial performance, quality, risk and utilization to help them establish trust with providers, maximize revenue and scale their value-based arrangements. For more information, visit www.SpectraMedix.com.

Media Contact:

Nathan Brown  
Director of Marketing
388163@email4pr.com
(609) 638-2987

View original content to download multimedia:https://www.prnewswire.com/news-releases/spectramedix-expands-value-based-payment-vbp-contract-modeler-to-support-the-industrys-most-comprehensive-range-of-value-based-contract-types-302343162.html

SOURCE SpectraMedix

Staff

Recent Posts

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

20 hours ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

20 hours ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

20 hours ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

20 hours ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…

20 hours ago

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…

20 hours ago